Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven L Chang

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
Journal of Endourology|May 25, 2017
The Impact of Surgeon Volume on Perioperative Outcomes and Cost for Patients Receiving Robotic Partial NephrectomyYash S Khandwala, In Gab Jeong, Jae Heon Kim, et al.
The Journal of Urology|March 8, 2017
Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United StatesRoss E Krasnow, Matthew Mossanen, Sophia Koo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 25, 2018
Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapyMaxine Sun, Christian P Meyer, Jose A Karam, et al.
The Canadian Journal of Urology|October 4, 2017
Adrenalectomy for benign and malignant disease: utilization and outcomes by surgeon specialty and surgical approach from 2003-2013Izak Faiena, Alexandra Tabakin, Jeffrey Leow, et al.
Journal of Pediatric Urology|September 6, 2016
Robotic versus open pediatric ureteral reimplantation: Costs and complications from a nationwide sampleMichael P Kurtz, Jeffrey J Leow, Briony K Varda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base StudyNawar Hanna, Maxine Sun, Christian P Meyer, et al.
European Urology|February 5, 2014
Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United StatesJeffrey J Leow, Stephen W Reese, Wei Jiang, et al.
European Urology|April 1, 2017
Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based AssessmentChristian P Meyer, Maxine Sun, Jose A Karam, et al.
World Journal of Urology|November 18, 2018
Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categoriesMatthew Mossanen, Ye Wang, Julie Szymaniak, et al.
Urology|April 9, 2020
Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical CystectomyJay Tzu-Hao Huang, Alexander P Cole, Matthew Mossanen, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Journal of Endourology|May 25, 2017
The Impact of Surgeon Volume on Perioperative Outcomes and Cost for Patients Receiving Robotic Partial NephrectomyYash S Khandwala, In Gab Jeong, Jae Heon Kim, et al.
The Journal of Urology|March 8, 2017
Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United StatesRoss E Krasnow, Matthew Mossanen, Sophia Koo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 25, 2018
Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapyMaxine Sun, Christian P Meyer, Jose A Karam, et al.
The Canadian Journal of Urology|October 4, 2017
Adrenalectomy for benign and malignant disease: utilization and outcomes by surgeon specialty and surgical approach from 2003-2013Izak Faiena, Alexandra Tabakin, Jeffrey Leow, et al.
Journal of Pediatric Urology|September 6, 2016
Robotic versus open pediatric ureteral reimplantation: Costs and complications from a nationwide sampleMichael P Kurtz, Jeffrey J Leow, Briony K Varda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base StudyNawar Hanna, Maxine Sun, Christian P Meyer, et al.
European Urology|February 5, 2014
Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United StatesJeffrey J Leow, Stephen W Reese, Wei Jiang, et al.
European Urology|April 1, 2017
Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based AssessmentChristian P Meyer, Maxine Sun, Jose A Karam, et al.
World Journal of Urology|November 18, 2018
Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categoriesMatthew Mossanen, Ye Wang, Julie Szymaniak, et al.
Urology|April 9, 2020
Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical CystectomyJay Tzu-Hao Huang, Alexander P Cole, Matthew Mossanen, et al.
Pageof 15